| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.74B | +10.8% |
| Cost of Revenue | $984.0M | +17.7% |
| Gross Profit | $2.76B | +8.5% |
| R&D Expense | $650.0M | +7.6% |
| SG&A Expense | $482.0M | +32.8% |
| Operating Income | $498.0M | +1.8% |
| Pre-tax Income | $556.0M | +0.7% |
| Income Tax | $109.0M | +14.7% |
| Net Income | $447.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $637.0M | -50.2% |
| Short-term Investments | $50.0M | -45.1% |
| Accounts Receivable | $1.13B | +11.1% |
| Current Assets | $2.20B | -18.5% |
| Total Assets | $3.69B | -10.4% |
| Current Liabilities | $917.0M | +14.9% |
| Total Liabilities | $974.0M | +16.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $971.0M | +41.3% |
| Capital Expenditures | $61.0M | -4.7% |
| Investing Cash Flow | -$208.0M | -94.4% |
| Financing Cash Flow | -$1.39B | +1.6% |
| Free Cash Flow | $910.0M | +46.1% |
| -2.2% |
| EPS (Basic) | $1.68 | -0.6% |
| EPS (Diluted) | $1.60 | +1.3% |
| Stockholders' Equity |
| $2.52B |
| -18.6% |